Please login to the form below

Forixiga

This page shows the latest Forixiga news and features for those working in and with pharma, biotech and healthcare.

AZ gets US approval for diabetes combo Qtern

Qtern is a fixed dose combination product based on the active ingredients in AZ's DPP-4 inhibitor Onglyza (saxagliptin) and SGLT2 inhibitor Farxiga/Forixiga (dapagliflozin).

Latest news

EU clears AZ's FDA-rejected diabetes combination

Qtern combines the active ingredients in AZ's DPP-4 inhibitor Onglyza (saxagliptin) with SGLT2 inhibitor Farxiga/Forixiga (saxagliptin), and is the second drug of its type on the market after
FDA rejects AZ's diabetes combination

The combination of DPP-4 inhibitor saxagliptin - sold by AZ as Onglyza - and SGLT2 inhibitor dapagliflozin (marketed as Farxiga/Forixiga) is considered to be a key component of the company's

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Account Manager or AD - Medical Communications: Salary TBC

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Senior Account Manager – Med Comms – Kent: Salary TBC

Editorial Director – Medical Education – Oxford: Negotiable

Senior Medical Writer: Great salary and benefits

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Account Manager – Med Comms – London: Salary TBC

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Account Manager / Account Director: Great salary and bebefits

Editor – Medical Education Agency – Bucks: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior Medical Writer: Great salary and bebefits

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Scientific Director: Great salary and bebefits

Senior Programme Executive: Salary TBC

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Subscribe to our email news alerts

PMHub

Add my company

Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...